Are we over treating axillae following a positive axillary lymph node biopsy? by Ball, W et al.
ABSTRACTS S271P7. Intra-operative margin detection using Cerenkov Luminescence
Imaging during radical prostatectomy e Initial results from the
PRIME study
Constance Michel1, Alex Freeman1, Charles Jameson1,
Wendy Waddington1, David Tuch3, Morten Harboe3, Paul Cathcart1,2
1 University College of London Hospital, London, UK
2Guy’s and Saint Thomas’ Hospital, London, UK
3Lightpoint Medical Ltd, London, UK
Objectives: Cerenkov Luminescence Imaging (CLI) is an optical im-
aging of PET radiopharmaceuticals. The PRIME (PRostate Imaging for
Margin Evaluation) study is evaluating the feasibility and safety of 18F-
choline CLI to intra-operatively assess margin status in prostate cancer
and lymph node specimens, during radical robotic prostatectomy.
Methods: Initial data from 3 patients are reported. After intravenous
injection of 18F-choline, the specimens were imaged intra-operatively
with an investigational CLI specimen analyser (Lightpoint Medical Ltd,
UK), just after the excision. The normalised decay-corrected radiance
(ph/s/cm2/str/MBq) was calculated for each region of interest and the
apparent tumour-to-background ratio (TBR) was reported. Radiation doses
to staff were measured using badge dosimeters.
Results: Intra-operative CLI of 3 prostatectomies showed an elevated
radiance with TBR 3.45, 4.90 and 2.49 respectively for each patient. For 2
prostates with high-grade disease, CLI analyses agreed with histological
reports but not for the third one, which was a low-grade. Lymph nodes
were negatives both on CLI and pathology reports. No surgical complica-
tion occurred due to the CLI protocol. Staff radiation doses are reported in
table 1. Additional environmental precautions were taken to allow for
radioactive decay.Table 1
Average staff radiation doses during the 3 CLI procedures
Radiation dose in mSv
Assisting surgeon 145
Scrub nurse 60
Anaesthetic staff <20
All other staff <10Conclusions: Intra-operative 18 F-choline CLI is a promising, feasible
and low risk procedure. Further development is required to restrict the CLI
signal to the surgical margin depths used in pathology.
http://dx.doi.org/10.1016/j.ejso.2015.08.112
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Introduction: Anastomosis leak is a common source of morbidity in
colorectal cancer resections and has been associated to a negative impact
upon survival, independent of tumour staging. C-Reactive Protein (CRP;
125e190 mg/L) has been applied as a negative predictive tool for anasto-
motic leak, but majority of cases are either open, emergency or non-malig-
nant resections.
Hypothesis: CRP can be used as a predictive tool for anastomotic leak
in both laparoscopic and open rectal resections, with laparoscopic resec-
tions showing a lesser predictive CRP value.
Methods: Consecutive rectal cancer resection patients with an anasto-
mosis performed between 2010 and 2014. Basic anonymous patient datawas collected including CRP results for day 1e7 and complications. Anas-
tomotic leak was confirmed via CT imaging. Outcomes were statistically
assessed with receiver operating curves (ROC) analysis.
Results: There were a total of 379 (131 Open; 248 laparoscopic) pa-
tients, with a total of 49 (12.9%) anastomotic leaks: 26 in the open group
and 23 in laparoscopic group. In laparoscopic resections, ROC analysis
suggests day 3 CRP of 157 (ROC area: 0.713, sensitivity: 0.700, speci-
ficity: 0.753) is predictive of anastomotic leak. Comparatively in open re-
sections, ROC analysis suggests day 3 CRP of 207 (ROC area: 0.765,
sensitivity: 0.765, specificity: 0.700) is predictive.
Conclusion: CRP, in both laparoscopic and open rectal resections, is
an excellent predictive test for an anastomotic leak; best seen at day 3.
Furthermore, Laparoscopic resections have a much lower predictive
threshold than open resections throughout all days reviewed, impacting
upon clinical concern in these subgroups.
http://dx.doi.org/10.1016/j.ejso.2015.08.113
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Introduction: Axillary lymph node status is the most significant single
prognostic factor in breast cancer. Due to the effectiveness of current adju-
vant therapy there is debate regarding the benefit of axillary node clearance
(ANC), which can carry significant morbidity.
Aim: To establish if our centre is over treating preoperatively staged
axillae.
Methods: Retrospective data collection on ANC following histologi-
cally confirmed positive ultrasound (US) axillae July 2009 to November
2014. Including demographics, grade of cancer, size of cancer, total num-
ber of lymph nodes in clearance and number of positive nodes. Compari-
son was made to previously collected data on ANC following positive One
Step Nucleic acid Amplification (OSNA). Two tailed Mann Whitney U sta-
tistical analysis was used.
Results: 100 US positive patients Vs 68 OSNA positive patients. ANC
performed for positive US axillae yields significantly more positive lymph
nodes than OSNA positive axillae (P¼ 0.00496). These patients also had
larger primary tumours (median 33 mm vs 25 mm P¼ 0.01242) of a higher
grade. In the OSNA group 43% patients had further positive nodes in their
ANC, only 19% had >/¼4 nodes; this was significantly less than in those
with positive US (p¼ 0.00104).
Conclusion: US positive axillae have a greater disease burden than
OSNA positive axillae; ANC is therefore indicated in these patients.
Removal of sentinel nodes for US negative axillae, which are subsequently
found to be positive on OSNA may be enough to treat metastatic disease
when combined with adjuvant therapy. Further studies will need to be per-
formed to establish this.
http://dx.doi.org/10.1016/j.ejso.2015.08.114
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